Home » Topics » Regulatory » Patents

Patents
RSS

Cathepsin L inhibitors with broad therapeutic potential from Takeda

Nov. 27, 1997

WB-2663B, a novel immunosuppressant isolated from Pseudomonas

Nov. 27, 1997

Agents activating beta3-adrenoceptors from Pfizer

Nov. 27, 1997

New V1 antagonists disclosed by Yamanouchi

Nov. 27, 1997

New erythromycins discovered at Roussel Uclaf

Nov. 27, 1997

PTK inhibitors for bone disorders from Novartis

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

Takeda develops potassium channel openers for cardiovascular indications

Nov. 26, 1997

New agents for heart disease prepared by Dainippon Ink & Chemicals

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...